SCHEMBL31702004

SCHEMBL31702004

COCCn1ccc(C(N)=O)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.40
PARP1 P09874 4/20 0.38
PARP10 Q53GL7 3/20 0.38
PARP2 Q9UGN5 2/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
PARP4 Q9UKK3 1/20 0.38
OPRM1 P35372 1/20 0.37
ALDH1A1 P00352 3/20 0.36
AKR1B1 P15121 1/20 0.36
CNR1 P21554 1/20 0.35
HCAR3 P49019 1/20 0.34
KDM4E B2RXH2 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PTGER4 P35408 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22063999 0.85 ALDH1A1 (0.47) TBXAS1CA1CA2ALDH1A1AKR1B1
SCHEMBL31701380 0.79 CA12 (0.47) TBXAS1PARP1PARP10PARP2CA1
SCHEMBL30098901 0.77 AKR1B1 (0.39) TBXAS1PARP1CA1CA2ALDH1A1
SCHEMBL20515231 0.77 AKR1B1 (0.39) TBXAS1PARP1PARP10CA1CA2
SCHEMBL4553409 0.77 AKR1B1 (0.41) PARP1PARP10PARP2CA1CA2
SCHEMBL4564716 0.77 KDM5A (0.41) ALDH1A1AKR1B1CNR1KDM4EHSD17B10
SCHEMBL3819996 0.76 AKR1B1 (0.43) TBXAS1PARP1PARP10PARP2CA1
SCHEMBL29038550 0.75 CNR1 (0.54) OPRM1ALDH1A1CNR1KDM4E
SCHEMBL29038572 0.75 CNR1 (0.54) OPRM1ALDH1A1CNR1KDM4E
SCHEMBL27945337 0.75 CNR1 (0.54) OPRM1ALDH1A1CNR1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250319063-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION PMV PHARMACEUTICALS, INC. 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250319063-A1 METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION TP53, TP53BP1, KRAS TBXAS1 2824/4885PARP1 865/4885PARP10 1556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.